All Stories

  1. Clinician factors influencing decision-making in emergency general surgery (EGS): a scoping review protocol
  2. Is It Stem Cell or Magic Potion? The Case of Autologous Fat Injection
  3. Gutflix ‘How to Develop Guidelines’ Series
  4. Clinical impact of double-faecal immunochemical testing following implementation into standard triage and investigation of primary care referrals in patients with lower gastrointestinal symptoms
  5. Risk factors and clinical consequences of interval cancers arising within faecal immunochemical testing-based colorectal cancer screening programme
  6. The Increased Early Onset Colorectal Cancer in South East Scotland Is Indicative of a Wider UK Problem
  7. Editorial April 2025: The protocolisation of evidence synthesis: The good, the bad and the ugly
  8. Editorial March 2025: Getting the guidelines we need
  9. What Constitutes a High‐Quality Guideline: Exploring Consumers' Views
  10. Look east for perianal fistula surgery
  11. Hearing what isn't said
  12. Diagnostic Performance of Faecal Immunochemical Testing (FIT) in Patients with Lynch Syndrome Scheduled for Colonoscopic Surveillance
  13. Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways
  14. Rainfall causing diverticulitis: A parable of data mining
  15. Quality of clinical guidelines: It matters as it impacts patient care
  16. The power of p
  17. Patients’ frailty and co-morbidities do not affect short-term mortality following emergency colorectal cancer surgery
  18. Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
  19. Oncological and clinical outcomes after conventional right hemicolectomy
  20. Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing
  21. European Society of Coloproctology guidance on the use of mesh in the pelvis in colorectal surgery
  22. Short‐term outcomes of a COVID‐adapted triage pathway for colorectal cancer detection
  23. Nurse-led telephone outreach for a COVID-adapted suspected colorectal cancer pathway
  24. Implementation of a risk mitigating COVID-adapted colorectal cancer pathway
  25. Posterior Tibial Nerve Stimulation for Faecal Incontinence
  26. Development of a customised data management system for a COVID-19-adapted colorectal cancer pathway
  27. The COVID‐19 pandemic: considerations for resuming normal colorectal services
  28. Healthcare apps: why have they not really taken off
  29. Risk mitigation for suspected colorectal cancer diagnostic pathway during COVID-19 pandemic
  30. Contemporary surgical practice in the management of anal fistula: results from an international survey
  31. Home parenteral nutrition and employment in patients with intestinal failure: Factors associated with return to employment
  32. The Renew® anal insert for passive faecal incontinence: a retrospective audit of our use of a novel device
  33. A review of the effect of faecal incontinence and constipation on sexual function
  34. Long-term outcome of laparoscopic rectopexy for full-thickness rectal prolapse
  35. Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review
  36. Mapping the current flow in sacral nerve stimulation using computational modelling.
  37. Regeneration of the oesophageal muscle layer from oesophagus acellular matrix scaffold using adipose-derived stem cells
  38. Assessment and management of patients with intestinal failure: a multidisciplinary approach
  39. Standardising assessment and documentation of pouchoscopy
  40. A meta-analysis comparing open anterior component separation with posterior component separation and transversus abdominis release in the repair of midline ventral hernias
  41. Hypoxia Enhances Differentiation of Adipose Tissue-Derived Stem Cells toward the Smooth Muscle Phenotype
  42. Combined Laparoscopic and Perineal Approach to Omental Interposition Repair of Complex Rectovaginal Fistula
  43. Current practice of continence advisors in managing faecal incontinence in the United Kingdom: results of an online survey
  44. The prevalence of chronic peri‐pouch sepsis in patients treated for antibiotic‐dependent or refractory primary idiopathic pouchitis
  45. Complex abdominal wall reconstruction in the setting of active infection and contamination: a systematic review of hernia and fistula recurrence rates
  46. Long-term outcome of sacral neuromodulation for chronic refractory constipation
  47. Major Complex Abdominal Wall Repair in Contaminated Fields with Use of a Non‐cross‐linked Biologic Mesh: A Dual‐Institutional Experience
  48. The role of the defaecating pouchogram in the assessment of evacuation difficulty after restorative proctocolectomy and pouch–anal anastomosis
  49. European Society of Coloproctology consensus on the surgical management of intestinal failure in adults
  50. Neuromodulation
  51. Sacral nerve stimulation for faecal incontinence and constipation: a European consensus statement
  52. Response to: consensus on ventral rectopexy: report of a panel of experts
  53. Outcome of Sacral Nerve Stimulation for Fecal Incontinence at 5 Years
  54. Patient Responses to Different Neuromodulatory Treatments
  55. Perianal injectable bulking agents as treatment for faecal incontinence in adults
  56. Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in patients with previous adenomas and/or genetic disposition
  57. Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing recurrence and metachronous colorectal carcinomas in patients previously treated for colorectal cancer
  58. The Problematic Sacral Neuromodulation
  59. Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in general population
  60. Sacral Nerve Stimulation for Fecal Incontinence
  61. Percutaneous tibial nerve stimulation for slow transit constipation: a pilot study
  62. Medium-Term Outcome of Sacral Nerve Modulation for Constipation
  63. Postoperative Issues of Sacral Nerve Stimulation for Fecal Incontinence and Constipation: A Systematic Literature Review and Treatment Guideline
  64. Long-term outcome of the use of botulinum toxin injection for functional anal pain
  65. Sacral Nerve Stimulation
  66. Gracilis muscle transposition for complex fistula and persistent nonhealing sinus in perianal Crohnʼs disease
  67. Faecal incontinence following radiotherapy for prostate cancer: A systematic review
  68. Suboptimal outcome following sacral nerve stimulation for faecal incontinence
  69. Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy
  70. Sacral Nerve Stimulation for Constipation: Suboptimal Outcome and Adverse Events
  71. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease
  72. Perianal injectable bulking agents as treatment for faecal incontinence in adults
  73. Predictors of the outcome of percutaneous nerve evaluation for faecal incontinence
  74. The role of pouch compliance measurement in the management of pouch dysfunction
  75. Retention Test in Sacral Nerve Stimulation for Fecal Incontinence
  76. Physiological, psychological and behavioural characteristics of men and women with faecal incontinence
  77. Perianal injectable bulking agents as treatment for faecal incontinence
  78. W1210 Clinical Outcome Measures of Response to Pharmacological Treatment in Perianal Crohn's Disease
  79. Open Hemorrhoidectomy
  80. Does the St. Mark's Incontinence Score Reflect Patients' Perceptions? A Review of 390 Patients
  81. Response to Smart et al.
  82. St. Mark's Incontinence Score
  83. Pilot study of two new injectable bulking agents for the treatment of faecal incontinence
  84. Long‐term results of perianal silicone injection for faecal incontinence
  85. Injectable Bulking Agents